At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4007 Pharmacy
Market Closed 01-16 16:00:00 EST
881.20
+2.96
+0.34%
High885.02Low875.82Vol656.86M
Open878.32D1 Closing878.25Amplitude1.05%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O22.79BT/O Rate--Tradable Shares0.00
P/B5.404864ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Assessing AtaiBeckley (ATAI) After A 149% Year Following Biotech Sector Sentiment Shift
Simply Wall St.  ·  04:32
Assessing AtaiBeckley (ATAI) After A 149% Year Following Biotech Sector Sentiment Shift
Assessing Indivior (NasdaqGS:INDV) Valuation After Recent Share Price Swings And DCF Upside Potential
Simply Wall St.  ·  04:27
Assessing Indivior (NasdaqGS:INDV) Valuation After Recent Share Price Swings And DCF Upside Potential
These 20 cheap S&P 500 stocks can cushion the blow in a market downturn
Dow Jones  ·  03:54
These 20 cheap S&P 500 stocks can cushion the blow in a market downturn
Assessing Terns Pharmaceuticals (TERN) Valuation After New TERN-701 Data And Capital Raise
Simply Wall St.  ·  00:24
Assessing Terns Pharmaceuticals (TERN) Valuation After New TERN-701 Data And Capital Raise
FDA Approves Extended Five-Year Use of Organon's NEXPLANON Contraceptive Implant
Reuters  ·  01-17 23:57
FDA Approves Extended Five-Year Use of Organon's NEXPLANON Contraceptive Implant
biote Corp.'s (NASDAQ:BTMD) latest 10% decline adds to one-year losses, institutional investors may consider drastic measures
Simply Wall St.  ·  01-17 21:06
biote Corp.'s (NASDAQ:BTMD) latest 10% decline adds to one-year losses, institutional investors may consider drastic measures
HuaBao Fund Infuriates Investors! "Nasdaq" Branded Fund Heavily Holds Loss-Making NIO
Deep News  ·  01-17 19:04
HuaBao Fund Infuriates Investors! "Nasdaq" Branded Fund Heavily Holds Loss-Making NIO
ANALYSIS-American CEOs push back on Trump ... mildly
Reuters  ·  01-17 19:00
ANALYSIS-American CEOs push back on Trump ... mildly
Does Breakthrough Status For Sacituzumab Tirumotecan-Keytruda Combo Reshape Kelun-Biotech’s Oncology Strategy (SEHK:6990)?
Simply Wall St.  ·  01-17 12:34
Does Breakthrough Status For Sacituzumab Tirumotecan-Keytruda Combo Reshape Kelun-Biotech’s Oncology Strategy (SEHK:6990)?
BRIEF-Organon Announces US FDA Approval Of Supplemental New Drug Application Extending Duration Of Use Of Nexplanon® 68 Mg Radiopaque
Reuters  ·  01-17 10:14
BRIEF-Organon Announces US FDA Approval Of Supplemental New Drug Application Extending Duration Of Use Of Nexplanon® 68 Mg Radiopaque
Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of Nexplanon® (Etonogestrel Implant) 68 Mg Radiopaque
THOMSON REUTERS  ·  01-17 10:12
Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of Nexplanon® (Etonogestrel Implant) 68 Mg Radiopaque
Organon & Co - Nexplanon Use Extended to Five Years
THOMSON REUTERS  ·  01-17 10:12
Organon & Co - Nexplanon Use Extended to Five Years
13D Filings -- Barrons.com
Dow Jones  ·  01-17 09:39
13D Filings -- Barrons.com
60 Degrees Pharmaceuticals Inc trading halted, news pending
TIPRANKS  ·  01-17 08:50
60 Degrees Pharmaceuticals Inc trading halted, news pending
VP of Operations Chris Wren Sells Common Shares of Planet 13 Holdings Inc
Reuters  ·  01-17 07:23
VP of Operations Chris Wren Sells Common Shares of Planet 13 Holdings Inc
Stocks to Watch: Atossa Therapeutics, Union Pacific
Dow Jones  ·  01-17 07:14
Stocks to Watch: Atossa Therapeutics, Union Pacific
Novo Nordisk's Wegovy Weight Loss Pill Has a Strong Launch - and Other Reasons the Stock Rises 9%
Dow Jones  ·  01-17 07:07
Novo Nordisk's Wegovy Weight Loss Pill Has a Strong Launch - and Other Reasons the Stock Rises 9%
Rein Therapeutics Raises Capital via Private Note Offering
TIPRANKS  ·  01-17 06:49
Rein Therapeutics Raises Capital via Private Note Offering
Artelo Biosciences Faces Nasdaq Delisting Over Annual Meeting Rule Violation
Reuters  ·  01-17 06:16
Artelo Biosciences Faces Nasdaq Delisting Over Annual Meeting Rule Violation
Coeptis Therapeutics Addresses Nasdaq Listing Compliance Deficiency
TIPRANKS  ·  01-17 06:03
Coeptis Therapeutics Addresses Nasdaq Listing Compliance Deficiency

Introduction

Company Name.
BK4007
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--